Nader Sanai
Clinical trials sponsored by Nader Sanai, explained in plain language.
-
Sound waves and Light-Activated drug tested against aggressive brain tumors
Disease control TerminatedThis early-phase study tested a new approach called sonodynamic therapy for people with recurrent high-grade glioma, a fast-growing brain tumor. Participants received a drug called ALA followed by focused ultrasound to activate it. The goal was to check safety and see if the trea…
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Disease control
Last updated May 18, 2026 12:13 UTC
-
Brain cancer drug penetration study halted early
Knowledge-focused TerminatedThis study aimed to see how much of the drug infigratinib gets into brain tumors in people with recurrent high-grade glioma (a type of brain cancer). Only 7 participants were enrolled before the study was stopped. The main goal was to measure drug levels in tumor tissue, blood, a…
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Knowledge-focused
Last updated May 26, 2026 04:37 UTC
-
New drug delivery method for brain tumors tested in small study
Knowledge-focused TerminatedThis early-stage trial enrolled 5 people with recurrent high-grade glioma (a type of aggressive brain tumor). Participants received a single dose of the drug temsirolimus, given directly into the brain's blood vessels or through a vein, on the same day as planned tumor removal su…
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Knowledge-focused
Last updated May 18, 2026 12:02 UTC